In vivo role of TPL2 activation in squamous cell carcinoma, keratoacanthoma-type development and progression

被引：0
|
作者：
Suh, J. [1 ]
Lee, J. [1 ]
Jung, J. [2 ]
Jeong, J. [1 ]
机构：
[1] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[2] USC, Los Angeles, CA USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2013年 / 133卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
396
引用
收藏
页码：S67 / S67
页数：1
相关论文
共 50 条
  • [21] Prognostic role of TPL2 in early-stage non-small cell lung cancer
    Boldrini, Laura
    Giordano, Mirella
    Servadio, Adele
    Niccoli, Cristina
    Bertoglio, Pietro
    Lucchi, Marco
    Melfi, Franca
    Mussi, Alfredo
    Fontanini, Gabriella
    MOLECULAR MEDICINE REPORTS, 2017, 15 (06) : 3451 - 3458
  • [22] BETA-2 MICROGLOBULIN EXPRESSION IN KERATOACANTHOMA AND SQUAMOUS-CELL CARCINOMA
    NASH, JRG
    GRAHAM, RM
    JOURNAL OF PATHOLOGY, 1987, 152 (03): : A237 - A237
  • [23] Understanding the role of kindlin-1 loss in the development and progression of squamous cell carcinoma
    Carrasco, D. Giovana
    Stravrou, Ifigeneia
    Xie, Wanfei
    Martin, Emily
    Muir, Morwenna
    Lee, Martin
    Byron, Adam
    Brunton, Valerie
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (06) : E229 - E229
  • [24] The role of NADPH oxidase 2 in tumor progression of esophageal squamous cell carcinoma
    Shimizu, Hiroki
    Shiozaki, Atsushi
    Katsurahara, Keita
    Inoue, Hiroyuki
    Kosuga, Toshiyuki
    Kudou, Michihiro
    Arita, Tomohiro
    Konishi, Hirotaka
    Komatsu, Shuhei
    Fujiwara, Hitoshi
    Otsuji, Eigo
    CANCER SCIENCE, 2023, 114 : 619 - 619
  • [25] Expression of PD-L1 in keratoacanthoma and different stages of progression in cutaneous squamous cell carcinoma
    Thilo Gambichler
    Martha Gnielka
    Ines Rüddel
    Eggert Stockfleth
    Markus Stücker
    Lutz Schmitz
    Cancer Immunology, Immunotherapy, 2017, 66 : 1199 - 1204
  • [26] Expression of PD-L1 in keratoacanthoma and different stages of progression in cutaneous squamous cell carcinoma
    Gambichler, Thilo
    Gnielka, Martha
    Rueddel, Ines
    Stockfleth, Eggert
    Stuecker, Markus
    Schmitz, Lutz
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (09) : 1199 - 1204
  • [27] Expression of PD-L1 in keratoacanthoma and different stages of progression in cutaneous squamous cell carcinoma
    Gambichler, T.
    Gnielka, M.
    Rueddel, I
    Stockfleth, E.
    Stuecker, M.
    Schmitz, L.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 : 41 - 42
  • [28] Essential role of IRAK4/TPL2 signaling axis in MAPK activation by oncogenic RAS and genotoxic stress
    Dodhiawala, Paarth B.
    Khurana, Namrata
    Zhang, Daoxiang
    Cheng, Yi
    Li, Lin
    Seehra, Kuljeet
    Jiang, Hongmei
    Grierson, Patrick M.
    Wang-Gillam, Andrea
    Ruzinova, Marianna B.
    Lim, Kian-Huat
    CANCER RESEARCH, 2020, 80 (16)
  • [29] Differences between squamous cell carcinoma and keratoacanthoma in angiotensin type-1 receptor expression
    Takeda, H
    Kondo, S
    AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (05): : 1633 - 1637
  • [30] Role of Activation-Induced Cytidine Deaminase in the Development of Oral Squamous Cell Carcinoma
    Nakanishi, Yosuke
    Kondo, Satoru
    Wakisaka, Naohiro
    Tsuji, Akira
    Endo, Kazuhira
    Murono, Shigeyuki
    Ito, Makoto
    Kitamura, Kouichi
    Muramatsu, Masamichi
    Yoshizaki, Tomokazu
    PLOS ONE, 2013, 8 (04):
12345